Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 6.58M | $50.0M | 15.33% | +5.78M | 2026-06-30 |
| Balyasny Asset Management L.P. | 3.63M | $28.0M | 8.45% | -- | 2026-06-30 |
| Woodline Partners LP | 3.00M | $23.0M | 7.00% | +2.00M | 2026-06-30 |
| Silverarc Capital Management, LLC | 2.93M | $22.0M | 6.83% | +2.89M | 2026-06-30 |
| Vanguard Capital Management LLC | 2.57M | $19.0M | 5.98% | +1.47M | 2026-06-30 |
| Bvf Inc | 2.50M | $19.0M | 5.83% | -- | 2026-06-30 |
| Caligan Partners LP | 2.50M | $19.0M | 5.83% | -- | 2026-06-30 |
| Federated Hermes, Inc. | 2.09M | $16.0M | 4.86% | +2.09M | 2026-06-30 |
| Great Point Partners LLC | 2.03M | $15.0M | 4.73% | -- | 2026-06-30 |
| State Street Corp | 2.00M | $15.0M | 4.65% | +1.87M | 2026-06-30 |
